OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
AKT as a Therapeutic Target for Cancer
Mengqiu Song, Ann M. Bode, Zigang Dong, et al.
Cancer Research (2019) Vol. 79, Iss. 6, pp. 1019-1031
Closed Access | Times Cited: 646
Mengqiu Song, Ann M. Bode, Zigang Dong, et al.
Cancer Research (2019) Vol. 79, Iss. 6, pp. 1019-1031
Closed Access | Times Cited: 646
Showing 26-50 of 646 citing articles:
Nexus between PI3K/AKT and Estrogen Receptor Signaling in Breast Cancer
Aditi S. Khatpe, Adedeji K. Adebayo, Christopher Herodotou, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 369-369
Open Access | Times Cited: 58
Aditi S. Khatpe, Adedeji K. Adebayo, Christopher Herodotou, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 369-369
Open Access | Times Cited: 58
Pharmacological review of isobavachalcone, a naturally occurring chalcone
Miaojuan Wang, Ligen Lin, Jin-Jian Lu, et al.
Pharmacological Research (2021) Vol. 165, pp. 105483-105483
Closed Access | Times Cited: 57
Miaojuan Wang, Ligen Lin, Jin-Jian Lu, et al.
Pharmacological Research (2021) Vol. 165, pp. 105483-105483
Closed Access | Times Cited: 57
Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways
Zhi Zhu, A. J. Robert McGray, Weijian Jiang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 54
Zhi Zhu, A. J. Robert McGray, Weijian Jiang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 54
Mechanism of Resveratrol-Induced Programmed Cell Death and New Drug Discovery against Cancer: A Review
Jung Yoon Jang, Eunok Im, Nam Deuk Kim
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13689-13689
Open Access | Times Cited: 54
Jung Yoon Jang, Eunok Im, Nam Deuk Kim
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13689-13689
Open Access | Times Cited: 54
Mutational signatures are markers of drug sensitivity of cancer cells
Jurica Levatić, Marina Salvadores, Francisco Fuster‐Tormo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 51
Jurica Levatić, Marina Salvadores, Francisco Fuster‐Tormo, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 51
Understanding the role of dopamine in cancer: past, present and future
Christopher E. Grant, Amy L. Flis, Bríd M. Ryan
Carcinogenesis (2022) Vol. 43, Iss. 6, pp. 517-527
Open Access | Times Cited: 45
Christopher E. Grant, Amy L. Flis, Bríd M. Ryan
Carcinogenesis (2022) Vol. 43, Iss. 6, pp. 517-527
Open Access | Times Cited: 45
Hierarchical Au nanoarrays functionalized 2D Ti2CTx MXene membranes for the detection of exosomes isolated from human lung carcinoma cells
Qiannan You, Linlin Zhuang, Zhimin Chang, et al.
Biosensors and Bioelectronics (2022) Vol. 216, pp. 114647-114647
Closed Access | Times Cited: 44
Qiannan You, Linlin Zhuang, Zhimin Chang, et al.
Biosensors and Bioelectronics (2022) Vol. 216, pp. 114647-114647
Closed Access | Times Cited: 44
Recent advances in PI3K/PKB/mTOR inhibitors as new anticancer agents
Maria Antonietta Occhiuzzi, Gernando Lico, Giuseppina Ioele, et al.
European Journal of Medicinal Chemistry (2022) Vol. 246, pp. 114971-114971
Closed Access | Times Cited: 41
Maria Antonietta Occhiuzzi, Gernando Lico, Giuseppina Ioele, et al.
European Journal of Medicinal Chemistry (2022) Vol. 246, pp. 114971-114971
Closed Access | Times Cited: 41
Fisetin Deters Cell Proliferation, Induces Apoptosis, Alleviates Oxidative Stress and Inflammation in Human Cancer Cells, HeLa
Nazia Afroze, Sreepoorna Pramodh, Jasmin Shafarin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1707-1707
Open Access | Times Cited: 39
Nazia Afroze, Sreepoorna Pramodh, Jasmin Shafarin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1707-1707
Open Access | Times Cited: 39
The Impact of Oxidative Stress and AKT Pathway on Cancer Cell Functions and Its Application to Natural Products
Jun‐Ping Shiau, Ya-Ting Chuang, Jen‐Yang Tang, et al.
Antioxidants (2022) Vol. 11, Iss. 9, pp. 1845-1845
Open Access | Times Cited: 39
Jun‐Ping Shiau, Ya-Ting Chuang, Jen‐Yang Tang, et al.
Antioxidants (2022) Vol. 11, Iss. 9, pp. 1845-1845
Open Access | Times Cited: 39
UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism
Zhenru Zhu, Chuanhui Cao, Dongyan Zhang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 37
Zhenru Zhu, Chuanhui Cao, Dongyan Zhang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 37
Pharmaceutical and nutraceutical activation of FOXO3 for healthy longevity
Rebecca L. McIntyre, Yasmine J. Liu, Man Hu, et al.
Ageing Research Reviews (2022) Vol. 78, pp. 101621-101621
Open Access | Times Cited: 37
Rebecca L. McIntyre, Yasmine J. Liu, Man Hu, et al.
Ageing Research Reviews (2022) Vol. 78, pp. 101621-101621
Open Access | Times Cited: 37
Metabolic reprogramming of immune cells in pancreatic cancer progression
Hong Xiang, Runjuan Yang, Jiaxin Tu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113992-113992
Open Access | Times Cited: 37
Hong Xiang, Runjuan Yang, Jiaxin Tu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113992-113992
Open Access | Times Cited: 37
Ferulic Acid: A Review of Pharmacology, Toxicology, and Therapeutic Effects on Pulmonary Diseases
Yiman Zhai, Tingyu Wang, Yunmei Fu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8011-8011
Open Access | Times Cited: 35
Yiman Zhai, Tingyu Wang, Yunmei Fu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8011-8011
Open Access | Times Cited: 35
Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases
Mengqiu Song, L. Pang, Mengmeng Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 29
Mengqiu Song, L. Pang, Mengmeng Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 29
Repurposing Antidepressants and Phenothiazine Antipsychotics as Efflux Pump Inhibitors in Cancer and Infectious Diseases
Bálint Rácz, Gabriella Spengler
Antibiotics (2023) Vol. 12, Iss. 1, pp. 137-137
Open Access | Times Cited: 28
Bálint Rácz, Gabriella Spengler
Antibiotics (2023) Vol. 12, Iss. 1, pp. 137-137
Open Access | Times Cited: 28
Yinjie Su, Bo Wang, Jian Huang, et al.
Cell Proliferation (2023) Vol. 56, Iss. 7
Open Access | Times Cited: 28
ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner
Weijian Wang, Qibo Huang, Zhibin Liao, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Weijian Wang, Qibo Huang, Zhibin Liao, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Circular MTHFD2L RNA-encoded CM-248aa inhibits gastric cancer progression by targeting the SET-PP2A interaction
Haohan Liu, Deliang Fang, Chaoyue Zhang, et al.
Molecular Therapy (2023) Vol. 31, Iss. 6, pp. 1739-1755
Open Access | Times Cited: 24
Haohan Liu, Deliang Fang, Chaoyue Zhang, et al.
Molecular Therapy (2023) Vol. 31, Iss. 6, pp. 1739-1755
Open Access | Times Cited: 24
Mitochondrial carrier 1 (MTCH1) governs ferroptosis by triggering the FoxO1-GPX4 axis-mediated retrograde signaling in cervical cancer cells
Xuan Wang, Yuting Ji, Jingyi Qi, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 24
Xuan Wang, Yuting Ji, Jingyi Qi, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 24
Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study
Heng‐Chung Kung, Jun Yu
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 23
Heng‐Chung Kung, Jun Yu
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 23
Investigating regulated signaling pathways in therapeutic targeting of non-small cell lung carcinoma
Manzar Alam, Gulam Mustafa Hasan, Sayed M. Eldin, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114452-114452
Open Access | Times Cited: 22
Manzar Alam, Gulam Mustafa Hasan, Sayed M. Eldin, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114452-114452
Open Access | Times Cited: 22
Proteogenomic insights suggest druggable pathways in endometrial carcinoma
Yongchao Dou, Lizabeth Katsnelson, Marina Gritsenko, et al.
Cancer Cell (2023) Vol. 41, Iss. 9, pp. 1586-1605.e15
Open Access | Times Cited: 22
Yongchao Dou, Lizabeth Katsnelson, Marina Gritsenko, et al.
Cancer Cell (2023) Vol. 41, Iss. 9, pp. 1586-1605.e15
Open Access | Times Cited: 22
TRPML1 triggers ferroptosis defense and is a potential therapeutic target in AKT-hyperactivated cancer
Hai‐Liang Zhang, Bingxin Hu, ZhenXiong Ye, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 753
Closed Access | Times Cited: 12
Hai‐Liang Zhang, Bingxin Hu, ZhenXiong Ye, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 753
Closed Access | Times Cited: 12
Chitosan-coated magnetic graphene oxide for targeted delivery of doxorubicin as a nanomedicine approach to treat glioblastoma
Banendu Sunder Dash, Yu‐Jen Lu, Ya‐Shu Huang, et al.
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129401-129401
Closed Access | Times Cited: 11
Banendu Sunder Dash, Yu‐Jen Lu, Ya‐Shu Huang, et al.
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129401-129401
Closed Access | Times Cited: 11
